Rapid RV/LV vs Optellum Virtual Nodule Clinic

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by RapidAI (formerly iSchemaView)
VS
by Optellum Ltd.

AI Verdict

Tool A, Rapid RV/LV, is specifically designed for the rapid assessment of pulmonary embolism severity by analyzing CTPA scans for ventricular ratios. In contrast, Tool B, Optellum Virtual Nodule Clinic, focuses on early lung cancer diagnosis and comprehensive lung nodule management, utilizing AI for malignancy risk assessment and patient tracking. While both are AI-powered clinical decision support tools for pulmonary conditions, they address distinct diseases and clinical workflows.

Choose Rapid RV/LV if…

Choose Rapid RV/LV if your primary need is immediate and objective assessment of pulmonary embolism (PE) severity. This tool is ideal for emergency departments or critical care settings where rapid, AI-powered measurement of right and left ventricle ratios from CTPA scans is crucial for quick patient triage and management decisions.

View Rapid RV/LV →

Choose Optellum Virtual Nodule Clinic if…

Choose Optellum Virtual Nodule Clinic if your focus is on comprehensive, long-term management and early diagnosis of lung cancer through systematic lung nodule tracking. This solution excels in screening programs or for managing incidental findings, providing AI-powered malignancy risk assessment, patient discovery, and workflow management integrated with EHR/PACS for ongoing patient care.

View Optellum Virtual Nodule Clinic →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Rapid RV/LV Optellum Virtual Nodule Clinic
Pricing Contact vendor for pricing information. Contact for pricing
Deployment On-premises (dedicated server or virtual machine) or hybrid (on-premises/cloud with secure link to cloud), connecting to hospital LAN/firewall. On-premise or private cloud options within hospital datacenter.
BAA Available Unknown Yes AI-estimated
FDA Status 1 AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Optellum Virtual Nodule Clinic

Optellum Virtual Nodule Clinic offers web application access via standard desktop web browsers and a comprehensive workflow management system with dashboards and patient tracking. This, combined with seamless EHR and PACS integration, suggests a more intuitive and integrated user experience for a broader range of clinical tasks compared to Rapid RV/LV's focus on rapid image analysis within its platform.

Clinical Value

Optellum Virtual Nodule Clinic

While both are FDA-cleared and address critical clinical needs, Optellum Virtual Nodule Clinic provides a broader, long-term impact through early lung cancer diagnosis and comprehensive nodule management, including clinically validated risk stratification and decision support. Rapid RV/LV focuses on rapid, objective assessment for acute pulmonary embolism severity.

Pricing & Value

Optellum Virtual Nodule Clinic

Optellum Virtual Nodule Clinic clearly outlines a reimbursement pathway, including specific Category III CPTu00ae codes and a Medicare payment assignment of $650.50 in 2025. This transparency provides a tangible financial value proposition for healthcare providers, which is absent from Rapid RV/LV's 'Contact vendor for pricing' approach.

Enterprise Readiness

Optellum Virtual Nodule Clinic

Both tools are FDA-cleared, HIPAA compliant, and offer BAA with flexible on-premise or private cloud deployment. However, Optellum Virtual Nodule Clinic explicitly highlights 'Seamless EHR and PACS integration (HL7, DICOM),' which is a crucial aspect for integrating into existing hospital IT ecosystems and ensuring enterprise readiness.

Innovation

Optellum Virtual Nodule Clinic

Both leverage AI for important clinical tasks. Optellum Virtual Nodule Clinic demonstrates broader AI innovation by not only providing a Lung Cancer Prediction (LCP) score but also utilizing 'Patient Discovery AI to identify nodules from radiology reports using NLP,' which is a more advanced and proactive application of AI for patient identification.

Support & Docs

Tie

Both companies appear to offer dedicated customer support and resources. RapidAI mentions '24/7/365 customer support' and a 'dedicated customer success team,' while Optellum also mentions a 'dedicated customer success team' and 'training and implementation support.' Without more specific details on the depth of documentation or the specifics of support tiers, it is difficult to definitively differentiate them.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Rapid RV/LV Optellum Virtual Nodule Clinic
Tool Name Rapid RV/LV Optellum Virtual Nodule Clinic
Company RapidAI (formerly iSchemaView) Optellum Ltd.
Description FDA-cleared AI tool for rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans. FDA-cleared, AI-powered clinical decision support software for early lung cancer diagnosis and comprehensive lung nodule management, integrating seamlessly with EHR and PACS.
Primary Clinical Focus Pulmonary Embolism Severity Assessment Early Lung Cancer Diagnosis and Nodule Management
Key Feature 1 AI-powered analysis of CTPA images AI-powered Lung Cancer Prediction (LCP) score for malignancy risk assessment
Key Feature 2 Automated measurement of right and left ventricle diameters Patient Discovery AI to identify nodules from radiology reports using NLP
Key Feature 3 Calculation of RV/LV ratio Workflow management system with incidental and screening dashboards

Videos

Demos, reviews, and walkthroughs featuring Rapid RV/LV and Optellum Virtual Nodule Clinic.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Rapid RV/LV is an FDA-cleared AI tool designed for the rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans. Optellum Virtual Nodule Clinic is an FDA-cleared, AI-powered clinical decision support software focused on early lung cancer diagnosis and comprehensive lung nodule management.
Rapid RV/LV offers on-premises or hybrid deployment, connecting to the hospital LAN/firewall and integrating with the broader Rapid PE solution. Optellum Virtual Nodule Clinic provides on-premise or private cloud options within the hospital datacenter and integrates seamlessly with EHR and PACS using HL7 and DICOM standards.
Rapid RV/LV provides AI-powered analysis of CTPA images to automatically measure right and left ventricle diameters, calculate the RV/LV ratio, and generate annotated images. Optellum Virtual Nodule Clinic offers an AI-powered Lung Cancer Prediction (LCP) score for malignancy risk assessment and Patient Discovery AI that uses NLP to identify nodules from radiology reports.
Optellum Virtual Nodule Clinic is reimbursable under CMS New Technology APC, and the AMA issued Category III CPTu00ae codes (0721T) for its utilization, with a Medicare payment assignment of $650.50 in 2025. The provided information for Rapid RV/LV does not detail specific reimbursement codes or mechanisms.
Rapid RV/LV provides rapid results within minutes of a scan, reducing inter-rater variability in PE severity assessment, and includes triage and notification capabilities as part of the Rapid platform. Optellum Virtual Nodule Clinic offers clinically validated risk stratification and decision support through its LCP score, along with a workflow management system featuring incidental and screening dashboards for patient tracking.

Backers

Who funded each tool's parent company.

Optellum Virtual Nodule Clinic

AI Tool Finder
AI-powered search. Results may not be comprehensive.